Bahrain grants emergency use for Pfizer, BioNTech Covid-19 vaccine
Coronavirus chronicle
04 December, 2020, 11:15 pm
Last modified: 04 December, 2020, 11:19 pm
“The confirmation of approval by the National Health Regulatory Authority of the kingdom of Bahrain followed thorough analysis and review undertaken by the authority of all available data”
Photo: Collected.
The island kingdom of Bahrain said Friday it has become the second nation in the world to grant an emergency-use authorisation for the coronavirus vaccine made by Pfizer and its German partner BioNTech.
The state-run Bahrain News Agency made the announcement on Friday night, following an earlier announcement by the United Kingdom on Wednesday, reports the AP News.
"The confirmation of approval by the National Health Regulatory Authority of the kingdom of Bahrain followed thorough analysis and review undertaken by the authority of all available data," the kingdom said on its state-run Bahrain News Agency.
Comments
While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.